Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,521 | 6,242 | 4,082 | 3,189 | 1,507 |
| Depreciation Amortization | 584 | 1,215 | 851 | 518 | 287 |
| Accounts receivable | 994 | -2,007 | -869 | 46 | 700 |
| Accounts payable and accrued liabilities | -329 | -1,123 | -532 | -579 | -238 |
| Other Working Capital | -1,634 | 438 | -211 | 4,393 | 1,787 |
| Other Operating Activity | -652 | 3,185 | 1,267 | 348 | -418 |
| Operating Cash Flow | $483 | $7,950 | $4,589 | $7,915 | $3,625 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -10 | -2,189 | 238 | -114 |
| Net Acquisitions | N/A | -335 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -4,747 | -2,602 | -2,591 | -2,581 |
| Other Investing Activity | 0 | -4,747 | -2,602 | -2,591 | -2,581 |
| Investing Cash Flow | $N/A | $-5,092 | $-4,791 | $-2,353 | $-2,695 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,154 | 4,409 | 1,568 | 1,562 |
| Common Stock Repurchased | N/A | -24 | -24 | N/A | N/A |
| Other Financing Activity | 1,946 | -3,265 | -7,133 | -3,104 | -1,531 |
| Financing Cash Flow | $1,946 | $-135 | $-2,748 | $-1,536 | $31 |
| Exchange Rate Effect | -44 | 704 | 1,086 | 1,158 | 621 |
| Beginning Cash Position | 35,152 | 31,725 | 31,725 | 31,725 | 31,725 |
| End Cash Position | 37,538 | 35,152 | 29,860 | 36,908 | 33,307 |
| Net Cash Flow | $2,386 | $3,427 | $-1,865 | $5,184 | $1,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | 483 | 7,950 | 4,589 | 7,915 | 3,625 |
| Capital Expenditure | N/A | -556 | -2,733 | -139 | -114 |
| Free Cash Flow | 483 | 7,395 | 1,856 | 7,776 | 3,511 |